Initiation and use of propranolol for infantile hemangioma: Report of a consensus conference

Pediatrics

Volumn 131, Issue 1, 2013, Pages 128-140

  Drolet, Beth A ^a   Frommelt, Peter C ^a   Chamlin, Sarah L ^b   Haggstrom, Anita ^c   Bauman, Nancy M ^d   Chiu, Yvonne E ^a   Chun, Robert H ^a   Garzon, Maria C ^e   Holland, Kristen E ^a   Liberman, Leonardo ^e   MacLellan Tobert, Susan ^f   Mancini, Anthony J ^b   Metry, Denise ^g   Puttgen, Katherine B ^h   Seefeldt, Marcia ⁱ   Sidbury, Robert ^j   Ward, Kendra M ^k   Blei, Francine ^l   Baselga, Eulalia ^m   Cassidy, Laura ^a   Darrow, David H ⁿ   Joachim, Shawna ^a   Kwon, Eun Kyung M ^a   Martin, Kari ^a   Perkins, Jonathan ^a   Siegel, Dawn H ^a   Boucek, Robert J ^j   Frieden, Ilona J ^o   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

ⁱ Children's Hospital of Wisconsin ^*  (United States)

^j SEATTLE CHILDREN S HOSPITAL   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l Vascular Birthmark Institute of New York   (United States)

^m HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁿ EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Bradycardia; Hypertension; Hypoglycemia; Infantile hemangioma; PHACE syndrome; Propranolol

Indexed keywords

PROPRANOLOL;

AIRWAY OBSTRUCTION; APNEA; ASYMPTOMATIC DISEASE; BRADYCARDIA; BRONCHIOLITIS; BRONCHOSPASM; CAPILLARY HEMANGIOMA; CLINICAL PROTOCOL; COLD LIMB; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DENTAL CARIES; DIARRHEA; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG OVERDOSE; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FIRST PASS EFFECT; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; HYPOTENSION; LOW DRUG DOSE; MORNING DOSAGE; NIGHTMARE; POSTERIOR FOSSA HEMANGIOMA ARTERIAL LESIONS CARDIAC ABNORMALITIES EYE ABNORMALITIES; PRIORITY JOURNAL; SEIZURE; SLEEP DISORDER; SOMNOLENCE; VASCULAR DISEASE; WHEEZING;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HEMANGIOMA; HUMANS; INFANT; PROPRANOLOL; RESEARCH REPORT; VASCULAR NEOPLASMS;

EID: 84872283531     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1691     Document Type: Conference Paper

References (119)

1. HCUPnet. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Available at: Http://www.ahrq.gov/data/hcup. Accessed March 31, 2010
2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics. 2006;118(3):882-887
3. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: Promise, peril, pathogenesis. Pediatr Dermatol. 2009;26 (5):642-644
4. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649-2651
5. Léauté-Labrèze C, Sans-Martin V. Hémangiome infantile [Infantile hemangioma]. Presse Med. 2010;39(4):499-510
6. Akhavan A, Zippin JH. Current treatments for infantile hemangiomas. J Drugs Dermatol. 2010;9(2):176-180
7. Baetz J, Eigelshoven S, Marquard J, Bruch-Gerharz D, Homey B, Meissner T. Infantiles Hämangiom. Erfolgreiche Behandlung mit Propranolo [Infantile hemangioma. Successful treatment with propranolol]. Hautarzt. 2010;61(4):290-292
8. Barrio VR, Drolet BA. Treatment of hemangiomas of infancy. Dermatol Ther. 2005;18(2):151-159
9. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104(6):1616-1623
10. Boyce J, Dodge-Palomba S. Propranolol treatment in periocular pediatric patients with hemangiomas. Insight. 2010;35(1): 22-23
11. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope. 2009;119(10):2051- 2054
12. Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg. 2009;17(6):458-459
13. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: Early experience at a tertiary vascular anomalies center. Laryngoscope. 2010;120(4):676-681
14. Denoyelle F, Garabédian EN. Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Otolaryngol Head Neck Surg. 2010; 142(3):463-464
15. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol. 2009;73(8): 1168-1172
16. Dickie B, Dasgupta R, Nair R, et al. Spectrum of hepatic hemangiomas: Management and outcome. J Pediatr Surg. 2009; 44(1):125-133
17. Draper H, Diamond IR, Temple M, John P, Ng V, Fecteau A. Multimodal management of endangering hepatic hemangioma: Impact on transplant avoidance: A descriptive case series. J Pediatr Surg. 2008;43(1):120-125, discussion 126
18. Fay A, Nguyen J, Jakobiec FA, Meyer-Junghaenel L, Waner M. Propranolol for isolated orbital infantile hemangioma. Arch Ophthalmol. 2010;128(2):256-258
19. Hara K, Yoshida T, Kajiume T, Ohno N, Kawaguchi H, Kobayashi M. Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging. Pediatr Hematol Oncol. 2009;26 (5):375-380
20. Herrero Hernández A, Escobosa Sánchez O, Acha García T. Successful treatment with vincristine in PHACES syndrome. Clin Transl Oncol. 2007;9(4):262-263
21. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for infantile hemangiomas. Plast Reconstr Surg. 2010;125(1):420-421
22. Hoyoux C. La vincristine: Nouveau traitement des hémangiomes infantiles? [Vincristine treatment for management of hemangiomas in infancy]. Rev Med Liege. 2008;63(1):14-17
23. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley BE. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol. 2009;73(12):1821-1823
24. Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol. 2010;38(6):554-559
25. Löffler H, Kosel C, Cremer H, Kachel W. Die Propranolol-Therapie in der Behandlung problematischer Hämangiome: Eine neue Standardtherapie kündigt sich an [Propranolol therapy to treat problematic hemangiomas : A new standard therapy makes its debut]. Hautarzt. 2009;60(12): 1013-1016
26. Fulkerson DH, Agim NG, Al-Shamy G, Metry DW, Izaddoost SA, Jea A. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: Case report and literature review. Childs Nerv Syst. 2010;26 (12):1799-1805
27. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: A case series of 30 infants. Br J Dermatol. 2010;162(2):466-468
28. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer. 2010;54(1):176
29. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol. 2010;74(3):323-325
30. Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol. 2010;124(12):1329-1332
31. Mousa W, Kues K, Haas E, et al. Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges. 2010;8 (3):184-186
32. Naouri M, Schill T, Maruani A, Bross F, Lorette G, Rossler J. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol. 2010;24(9): 1109-1112
33. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology. 2010;117(1):195.e4
34. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr. 2010;156(2):335-338
35. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol. 2010;163(2):269-274
36. Vanlander A, Decaluwe W, Vandelanotte M, Van Geet C, Cornette L. Propranolol as a novel treatment for congenital visceral haemangioma. Neonatology. 2010;98(3): 229-231
37. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: Follow-up report. Pediatrics. 2009; 124(3). Available at: Www.pediatrics.org/cgi/content/full/124/3/e423
38. Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas. Eur J Pediatr. 2011;170(4):493-501
39. Chim H, Armijo BS, Miller E, Gliniak C, Serret MA, Gosain AK. Propranolol induces regression of hemangioma cells through HIF-1a-mediated inhibition of VEGF-A. Ann Surg. 2012;256(1):146-156
40. Bayliss SJ, Berk DR, Van Hare GF, et al. Re: Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2010;27(3):319-320, author reply 320-321
41. Haider KM, Plager DA, Neely DE, Eikenberry J, Haggstrom A. Outpatient treatment of periocular infantile hemangiomas with oral propranolol. J AAPOS. 2010;14(3):251-256
42. Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol. 2010;38(6):547-553
43. Mishra A, Holmes WJ, Gorst C, Liew SH. Role of propranolol in the management of periocular hemangiomas. Plast Reconstr Surg. 2010;126(2):671
44. Erbay A, Sarialioglu F, Malbora B, et al. Propranolol for infantile hemangiomas: A preliminary report on efficacy and safety in very low birth weight infants. Turk J Pediatr. 2010;52(5):450-456
45. Chik KK, Luk CK, Chan HB, Tan HY. Use of propranolol in infantile haemangioma among Chinese children. Hong Kong Med J. 2010;16(5):341-346
46. Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol. 2010;74(11):1254-1257
47. Cushing SL, Boucek RJ, Manning SC, Sidbury R, Perkins JA. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas. Otolaryngol Head Neck Surg. 2011;144(1):78-84
48. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. J Plast Reconstr Aesthet Surg. 2011;64(3): 292-299
49. Zheng JW. Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma. Cutan Ocul Toxicol. 2011;30 (4):333-334
50. Zvulunov A, McCuaig C, Frieden IJ, et al. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: A multicenter retrospective study. Pediatr Dermatol. 2011;28(2):94-98
51. Bagazgoitia L, Torrelo A, Gutiérrez JC, et al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28(2):108-114
52. Mishra A, Holmes W, Gorst C, Liew S. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy. Plast Reconstr Surg. 2011;127(4):1742-1743; author reply 3
53. Kim LH, Hogeling M, Wargon O, Jiwane A, Adams S. Propranolol: Useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg. 2011;46(4):759-763
54. Fuchsmann C, Quintal MC, Giguere C, et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg. 2011;137(5): 471-478
55. Hermans DJ, van Beynum IM, Schultze Kool LJ, van de Kerkhof PC, Wijnen MH, van der Vleuten CJ. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: A study of 20 cases with matched historical controls. J Am Acad Dermatol. 2011;64(5):833-838
56. Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, et al; Groupe de Recherche Clinique en Dermatologie Pédiatrique. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64 (5):827-832
57. Al Dhaybi R, Superstein R, Milet A, et al. Treatment of periocular infantile hemangiomas with propranolol: Case series of 18 children. Ophthalmology. 2011;118(6): 1184-1188
58. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128(2). Available at: Www.pediatrics.org/cgi/content/full/128/2/e259
59. de Graaf M, Breur JM, Raphaël MF, Vos M, Breugem CC, Pasmans SG. Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants. J Am Acad Dermatol. 2011;65(2): 320-327
60. Truong MT, Perkins JA, Messner AH, Chang KW. Propranolol for the treatment of airway hemangiomas: A case series and treatment algorithm. Int J Pediatr Otorhinolaryngol. 2010;74(9):1043-1048
61. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: Risks and recommendations. Pediatr Dermatol. 2009;26(5):610-614
62. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening infantile haemangioma: A dramatic response to propranolol. J Eur Acad Dermatol Venereol. 2009;23(12):1465-1466
63. Bonifazi E, Acquafredda A, Milano A, Montagna O, Laforgia N. Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol. Pediatr Dermatol. 2010;27(2): 195-196
64. Holland KE, Frieden IJ, Frommelt PC, Mancini AJ, Wyatt D, Drolet BA. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol. 2010;146(7):775-778
65. Muthamilselvan S, Vinoth PN, Vilvanathan V, et al. Hepatic haemangioma of infancy: Role of propranolol. Ann Trop Paediatr. 2010;30(4):335-338
66. Blanchet C, Nicollas R, Bigorre M, Amedro P, Mondain M. Management of infantile subglottic hemangioma: Acebutolol or propranolol? Int J Pediatr Otorhinolaryngol. 2010;74(8):959-961
67. Arneja JS, Pappas PN, Shwayder TA, et al. Management of complicated facial hemangiomas with beta-blocker (propranolol) therapy. Plast Reconstr Surg. 2010;126(3):889-895
68. Abbott J, Parulekar M, Shahidullah H, Taibjee S, Moss C. Diarrhea associated with propranolol treatment for hemangioma of infancy (HOI). Pediatr Dermatol. 2010;27(5):558
69. Jadhav VM, Tolat SN. Dramatic response of propranolol in hemangioma: Report of two cases. Indian J Dermatol Venereol Leprol. 2010;76(6):691-694
70. Girón-Vallejo O, López-Gutiérrez JC, Fernández-Pineda I, Méndez NA, Ruiz Jiménez JI. Dental caries as a side effect of infantile hemangioma treatment with propranolol solution. Pediatr Dermatol. 2010;27(6):672-673
71. Sarialioglu F, Erbay A, Demir S. Response of infantile hepatic hemangioma to propranolol resistant to high-dose methylprednisolone and interferon-a therapy. Pediatr Blood Cancer. 2010;55(7):1433-1434
72. Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics. 2010;126(6). Available at: Www.pediatrics.org/cgi/content/full/126/6/e1589
73. Fabian ID, Ben-Zion I, Samuel C, Spierer A. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma. Am J Ophthalmol. 2011;151(1):53-58
74. Missoi TG, Lueder GT, Gilbertson K, Bayliss SJ. Oral propranolol for treatment of periocular infantile hemangiomas. Arch Ophthalmol. 2011;129(7):899-903
75. Claerhout I, Buijsrogge M, Delbeke P, et al. The use of propranolol in the treatment of periocular infantile haemangiomas: A review. Br J Ophthalmol. 2011;95(9):1199-1202
76. Javia LR, Zur KB, Jacobs IN. Evolving treatments in the management of laryngotracheal hemangiomas: Will propranolol supplant steroids and surgery? Int J Pediatr Otorhinolaryngol. 2011;75 (11):1450-1454
77. Rossler J, Schill T, Bähr A, Truckenmüller W, Noellke P, Niemeyer CM. Propranolol for proliferating infantile haemangioma is superior to corticosteroid therapy-a retrospective, single centre study. J Eur Acad Dermatol Venereol. 2012;26(9):1173-1175
78. El-Essawy R, Galal R, Abdelbaki S. Nonselective b-blocker propranolol for orbital and periorbital hemangiomas in infants: A new first-line of treatment? Clin Ophthalmol. 2011;5:1639-1644
79. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr. 2010;157(2): 340-342
80. Peridis S, Pilgrim G, Athanasopoulos I, Parpounas K. A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol. 2011;75(4): 455-460
81. Corapcioglu F, Büyükkapu-Bay S, Binnetoglu K, Babaoglu A, Anik Y, Tugay M. Preliminary results of propranolol treatment for patients with infantile hemangioma. Turk J Pediatr. 2011;53(2):137-141
82. Fridman G, Grieser E, Hill R, Khuddus N, Bersani T, Slonim C. Propranolol for the treatment of orbital infantile hemangiomas. Ophthal Plast Reconstr Surg. 2011;27 (3):190-194
83. Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Reports. 2009; doi:10.1136/bcr.01.2009.1476. Available at http://casereports.bmj.com/content/2009/bcr.01.2009.1476.abstract. Accessed October 30, 2012
84. Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg. 2010;136(7):658-665
85. Meyer L, Graffstaedt H, Giest H, Truebenbach J, Waner M. Effectiveness of propranolol in a newborn with liver hemangiomatosis. Eur J Pediatr Surg. 2010;20(6):414-415
86. Fusilli G, Merico G, Gurrado R, Rosa T, Acquafredda A, Cavallo L. Propranolol for infantile haemangiomas and neuroglycopenic seizures. Acta Paediatr. 2010; 99(12):1756
87. Mhanna A, Franklin WH, Mancini AJ. Hepatic infantile hemangiomas treated with oral propranolol-a case series. Pediatr Dermatol. 2011;28(1):39-45
88. Breur JM, de Graaf M, Breugem CC, Pasmans SG. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: A case report. Pediatr Dermatol. 2011;28(2):169-171
89. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics. 2011;127(3). Available at: Www.pediatrics.org/cgi/content/full/127/3/e772
90. Blatt J, Morrell DS, Buck S, et al. b-blockers for infantile hemangiomas: A single-institution experience. Clin Pediatr (Phila). 2011;50(8):757-763
91. Weiss I, Lipari BA,Meyer L, BerensteinA, Waner M. Current treatment of parotid hemangiomas. Laryngoscope. 2011;121(8): 1642-1650
92. Eivazi B, Cremer HJ, Mangold C, Teymoortash A, Wiegand S, Werner JA. Hemangiomas of the nasal tip: An approach to a therapeutic challenge. Int J Pediatr Otorhinolaryngol. 2011;75(3):368-375
93. Sierpina DI, Chaudhary HM, Walner DL, Aljadeff G, Dubrow IW. An infantile bronchial hemangioma unresponsive to propranolol therapy: Case report and literature review. Arch Otolaryngol Head Neck Surg. 2011;137(5):517-521
94. Yeh I, Bruckner AL, Sanchez R, Jeng MR, Newell BD, Frieden IJ. Diffuse infantile hepatic hemangiomas: A report of four cases successfully managed with medical therapy. Pediatr Dermatol. 2011;28(3): 267-275
95. Koay AC, Choo MM, Nathan AM, Omar A, Lim CT. Combined low-dose oral propranolol and oral prednisolone as firstline treatment in periocular infantile hemangiomas. J Ocul Pharmacol Ther. 2011;27(3):309-311
96. Tamagno M, Bibas BJ, Minamoto H, Alfinito FS, Terra RM, Jatene FB. Subglottic and mediastinal hemangioma in a child: Treatment with propranolol. J Bras Pneumol. 2011;37(3):416-418
97. Guye E, Chollet-Rivier M, Schröder D, Sandu K, Hohlfeld J, de Buys Roessingh A. Propranolol treatment for subglottic haemangioma. Arch Dis Child Fetal Neonatal Ed. 2011;96(4):F263-F264
98. Raol N, Metry D, Edmonds J, Chandy B, Sulek M, Larrier D. Propranolol for the treatment of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol. 2011;75(12): 1510-1514
99. Goswamy J, Rothera MP, Bruce IA. Failure of propranolol in the treatment of childhood haemangiomas of the head and neck. J Laryngol Otol. 2011;125(11):1164-1172
100. Moschovi M, Alexiou GA, Stefanaki K, Tourkantoni N, Prodromou N. Propranolol treatment for a giant infantile brain cavernoma. J Child Neurol. 2010;25(5):653-655
101. Canadas KT, Baum ED, Lee S, Ostrower ST. Case report: Treatment failure using propanolol for treatment of focal subglottic hemangioma. Int J Pediatr Otorhinolaryngol. 2010;74(8):956-958
102. Chun YH, Moon CJ, Yoon JS, Kim HH, Kim JT, Lee JS. Successful treatment of infantile subglottic hemangioma with oral propranolol. Clin Pediatr (Phila). 2012;51 (10):983-986
103. Holmes WJ, Mishra A, Gorst C, Liew SH. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas. J Plast Reconstr Aesthet Surg. 2011; 64(4):445-451
104. Hermans DJ, van Beynum IM, van der Vijver RJ, Kool LJ, de Blaauw I, van der Vleuten CJ. Kaposiform hemangioendothelioma with Kasabach-Merritt syndrome: A new indication for propranolol treatment. J Pediatr Hematol Oncol. 2011;33(4):e171-e173
105. Litovitz TL, Schmitz BF, Matyunas N, Martin TG. 1987 annual report of the American Association of Poison Control Centers National Data Collection System. Am J Emerg Med. 1988;6(5):479-515
106. Love JN, Litovitz TL, Howell JM, Clancy C. Characterization of fatal beta blocker ingestion: A review of the American Association of Poison Control Centers data from 1985 to 1995. J Toxicol Clin Toxicol. 1997;35 (4):353-359
107. Price CJ, Lattouf C, Baum B, et al. Propranolol vs corticosteroids for infantile hemangiomas: A multicenter retrospective analysis. Arch Dermatol. 2011;147(12): 1371-1376
108. van Veen MR, van Hasselt PM, de Sain-van der Velden MG, et al. Metabolic profiles in children during fasting. Pediatrics. 2011; 127(4). Available at: Www.pediatrics.org/cgi/content/full/127/4/e1021
109. Cavalli R, Buffon RB, de Souza M, Colli AM, Gelmetti C. Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: Rare complication or incidental finding? Dermatology. 2012;224 (2):106-109
110. Horton JN. Nominal group technique. A method of decision-making by committee. Anaesthesia. 1980;35(8):811-814
111. Michaëlsson M, Engle MA. Congenital complete heart block: An international study of the natural history. Cardiovasc Clin. 1972;4(3):85-101
112. Vetter VL, Rashkind WJ. Congenital complete heart block and connective-tissue disease. N Engl J Med. 1983;309(4):236-238
113. Bernstein DP, ed. History and Physical Evaluation. 18th ed. Philadelphia, PA: Saunders Elsevier; 2007
114. Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996;132(3):307-311
115. Solomon T, Ninnis J, Deming D, Merritt TA, Hopper A. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol. 2011;31(11):739-741
116. Siegel D, Tefft K, Kelly T, et al. Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardia defects, and eye abnormalities (PHACE) syndrome: A systematic review of the literature. Stroke. 2012;43(6):1672-1674
117. Webb AJ, Fischer U, Rothwell PM. Effects of b-blocker selectivity on blood pressure variability and stroke: A systematic review. Neurology. 2011;77(8):731-737
118. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(suppl 2, 4th report): 555-576
119. Kent AL, Kecskes Z, Shadbolt B, Falk MC. Blood pressure in the first year of life in healthy infants born at term. Pediatr Nephrol. 2007;22(10):1743-1749